Myeloid leukemia

Results: 723



#Item
131Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells

Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-11-21 09:53:44
132Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID[removed], 4 pages http://dx.doi.org[removed][removed]Case Report

Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID[removed], 4 pages http://dx.doi.org[removed][removed]Case Report

Add to Reading List

Source URL: downloads.hindawi.com

Language: English - Date: 2015-02-10 03:08:07
133SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of

SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
134SGI-110, a novel 5-aza-2’-deoxycytidine containing dinucleotide, induces Cancer Germline (CG) antigen expression in Acute Myeloid Leukemia cells Abstract #681 Elizabeth A. Griffiths1, Pragya Srivastava1, Golda Collamat

SGI-110, a novel 5-aza-2’-deoxycytidine containing dinucleotide, induces Cancer Germline (CG) antigen expression in Acute Myeloid Leukemia cells Abstract #681 Elizabeth A. Griffiths1, Pragya Srivastava1, Golda Collamat

Add to Reading List

Source URL: astx.com

Language: English
135Results From the Dose Escalation Phase of a Randomized Phase 1–2 First-in-Human (FIH) Study of SGI-110, a Novel Low Volume Stable Subcutaneous (SQ) Second Generation Hypomethylating Agent (HMA) in Patients with Relapse

Results From the Dose Escalation Phase of a Randomized Phase 1–2 First-in-Human (FIH) Study of SGI-110, a Novel Low Volume Stable Subcutaneous (SQ) Second Generation Hypomethylating Agent (HMA) in Patients with Relapse

Add to Reading List

Source URL: astx.com

Language: English - Date: 2013-05-20 15:28:50
136Study of the correlation of baseline biomarkers and DNA demethylation to clinical responses in a phase 1/2, randomized study of SGI-110, a novel subcutaneous hypomethylating agent in the treatment of relapsed/refractory

Study of the correlation of baseline biomarkers and DNA demethylation to clinical responses in a phase 1/2, randomized study of SGI-110, a novel subcutaneous hypomethylating agent in the treatment of relapsed/refractory

Add to Reading List

Source URL: astx.com

Language: English
137First clinical results of a randomized phase 2 study of SGI-110, a novel subcutaneous (SQ) hypomethylating agent (HMA), in adult patients with acute myeloid leukemia (AML) Jean Pierre Issa, MD Fels Institute, Temple Univ

First clinical results of a randomized phase 2 study of SGI-110, a novel subcutaneous (SQ) hypomethylating agent (HMA), in adult patients with acute myeloid leukemia (AML) Jean Pierre Issa, MD Fels Institute, Temple Univ

Add to Reading List

Source URL: astx.com

Language: English
138Abstract No[removed]Identification of Novel Methylation Biomarkers to Predict Clinical Response to SGI-110, a Second Generation Hypomethylating Agent (HMA), in Patients with Acute Myeloid Leukaemia (AML) Simone Jueliger1,

Abstract No[removed]Identification of Novel Methylation Biomarkers to Predict Clinical Response to SGI-110, a Second Generation Hypomethylating Agent (HMA), in Patients with Acute Myeloid Leukaemia (AML) Simone Jueliger1,

Add to Reading List

Source URL: astx.com

Language: English
139LC Paper No. CB[removed]) 7 March 2005 Dear Legislative Councillors, Subject: Standard Drug Formulary and Public Healthcare System On behalf of Chronic Myeloid Leukaemia (CML) and Gastrointestinal Stromal Tumour (

LC Paper No. CB[removed]) 7 March 2005 Dear Legislative Councillors, Subject: Standard Drug Formulary and Public Healthcare System On behalf of Chronic Myeloid Leukaemia (CML) and Gastrointestinal Stromal Tumour (

Add to Reading List

Source URL: www.legco.gov.hk

Language: English - Date: 2005-10-19 22:47:56
140Microsoft Word - FINAL CML Report dated 28 September 04.doc

Microsoft Word - FINAL CML Report dated 28 September 04.doc

Add to Reading List

Source URL: www.otago.ac.nz

Language: English